论文部分内容阅读
目的探讨PTCD与EMBE在老年恶性梗阻性黄疸治疗中的应用价值。方法回顾分析行PTCD或EMBE治疗的老年恶性梗阻性黄疸患者各20例的临床资料。结果 PTCD组术后第1周总胆红素自(269.36±107.42)μmol/L下降至(158.86±72.62)μmol/L,EMBE组术后第1周总胆红素自(258.31±73.81)μmol/L下降至(147.11±55.75)μmol/L,两组治疗前后数值差异具有统计学意义(P<0.05),两组间比较差异无统计学意义(P>0.05),两组患者术后的生存期平均为(14.6±8.32)周和(17.8±10.48)周,两组比较差异无统计学意义(P>0.05)。结论 PTCD与EMBE是姑息性治疗老年恶性梗阻性黄疸的有效方法。
Objective To investigate the value of PTCD and EMBE in the treatment of senile malignant obstructive jaundice. Methods The clinical data of 20 patients with senile malignant obstructive jaundice treated with PTCD or EMBE were retrospectively analyzed. Results The total bilirubin in PTCD group decreased from (269.36 ± 107.42) μmol / L to (158.86 ± 72.62) μmol / L in the first week after operation, and the level of total bilirubin in the first week after operation in EMBE group was (258.31 ± 73.81) μmol / L to (147.11 ± 55.75) μmol / L, the difference between the two groups before and after treatment was statistically significant (P <0.05), there was no significant difference between the two groups (P> 0.05) The average survival time was (14.6 ± 8.32) weeks and (17.8 ± 10.48) weeks, respectively. There was no significant difference between the two groups (P> 0.05). Conclusion PTCD and EMBE are palliative treatment of senile malignant obstructive jaundice.